GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 484 (1-2), 297-303
- https://doi.org/10.1016/0006-8993(89)90373-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment with GM1 Ganglioside Restores Striatal Dopamine in the 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐Treated MouseJournal of Neurochemistry, 1988
- GM1 ganglioside protects against the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐ induced degeneration of nigrostriatal dopamine neurons in the black mouseActa Physiologica Scandinavica, 1988
- Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosidesNeuroscience Letters, 1987
- 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayNature, 1986
- Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brainDevelopmental Brain Research, 1984
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Activation of (Na+, K+)‐ATPase by Nanomolar Concentrations of GM1 GangliosideJournal of Neurochemistry, 1981
- Estimation of nuclear population from microtome sectionsThe Anatomical Record, 1946